|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 170 JPY | -1.16% |
|
-2.30% | -31.17% |
SymBio Pharmaceuticals Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was JPY 5,589.71 million compared to JPY 10,008.34 million a year ago. Net loss was JPY 1,962.82 million compared to net income of JPY 1,179.24 million a year ago.
Basic loss per share from continuing operations was JPY 49.19 compared to basic earnings per share from continuing operations of JPY 30.2 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -31.17% | 51.17M | |
| +31.52% | 690B | |
| +24.57% | 546B | |
| -5.21% | 358B | |
| +17.02% | 323B | |
| +5.01% | 287B | |
| +14.00% | 235B | |
| +5.11% | 199B | |
| -9.94% | 195B | |
| +3.98% | 161B |
SYMBIO PHARMACEUTICALS LIMITED 